Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial

Primatesta, 2006, Improvement in hypertension management in England: results from the Health Survey for England 2003, J Hypertens, 24, 1193, 10.1097/01.hjh.0000226210.95936.bc Chobanian, 2003, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report, JAMA, 289, 2560, 10.1001/jama.289.19.2560 Mancia, 2007, 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Eur Heart J, 28, 1462 Julius, 2004, Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial, Lancet, 363, 2022, 10.1016/S0140-6736(04)16451-9 Turnbull, 2003, Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials, Lancet, 362, 1527, 10.1016/S0140-6736(03)14739-3 Dahlof, 2005, Lancet, 366, 895, 10.1016/S0140-6736(05)67185-1 Wald, 2009, Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials, Am J Med, 122, 290, 10.1016/j.amjmed.2008.09.038 Braun-Dullaeus, 2010, First-line therapy with aliskiren/amlodipine combination provides robust blood pressure reductions in patients with moderate to severe hypertension, J Clin Hypertens, 12, A27 Brown, 2008, Aliskiren, Circulation, 118, 773, 10.1161/CIRCULATIONAHA.108.787630 Brown, 2007, Renin: friend or foe?, Heart, 93, 1026, 10.1136/hrt.2006.107706 Zappe, 2010, Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension, J Hum Hypertens, 24, 483, 10.1038/jhh.2009.90 Feldman, 2009, A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial, Hypertension, 53, 646, 10.1161/HYPERTENSIONAHA.108.123455 Philipp, 2007, Clin Ther, 29, 563, 10.1016/j.clinthera.2007.03.018 Chrysant, 2008, The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study, Clin Ther, 30, 587, 10.1016/j.clinthera.2008.04.002 2006 Dahlöf, 2002, Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol, Lancet, 359, 995, 10.1016/S0140-6736(02)08089-3 Jamerson, 2008, Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients, N Engl J Med, 359, 2417, 10.1056/NEJMoa0806182 Fogari, 2007, Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study, Clin Ther, 29, 413, 10.1016/S0149-2918(07)80079-8 Messerli, 2000, Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension, Am J Cardiol, 86, 1182, 10.1016/S0002-9149(00)01199-1 Fogari, 2007, Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients, J Hum Hypertens, 21, 220, 10.1038/sj.jhh.1002140 Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 Newton-Cheh, 2009, Genome-wide association study identifies eight loci associated with blood pressure, Nat Genet, 41, 666, 10.1038/ng.361 Bakris, 2003, Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches, J Clin Hypertens (Greenwich), 5, 202, 10.1111/j.1524-6175.2002.2041.x Law, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, BMJ, 338, b1665, 10.1136/bmj.b1665 Laragh, 1979, Renin profiling for diagnosis and treatment of hypertension, JAMA, 241, 151, 10.1001/jama.1979.03290280031022 Brown, 2010, Heterogeneity of blood pressure response to therapy, Am J Hypertens, 23, 926, 10.1038/ajh.2010.139 Hood, 2007, The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio, Circulation, 116, 268, 10.1161/CIRCULATIONAHA.107.690396 Kaplan, 1976, The intravenous furosemide test: a simple way to evaluate renin responsiveness, Ann Intern Med, 84, 639, 10.7326/0003-4819-84-6-639 Brown, 1995, Alpha-blockade and calcium antagonism: an effective and well-tolerated combination for the treatment of resistant hypertension, J Hypertens, 13, 701, 10.1097/00004872-199506000-00018